CD44 and cancer: TNBC is enriched in cancer stem cell populations, and CSCs are distinguished from other cancer cells by the expression of cell surface markers CD44+/CD24− [4,17] and overexpression of octamer-binding transcription factor 3/4 (OCT-3/4) [18].